‘Shocked’ Wright CEO Plans Appeal on Augment ‘Not Approvable’ Letter

Wright Medical said it will appeal the FDA’s decision not to approve the Augment bone graft as an alternative to autograft in hind foot and ankle fusion procedures. The “not approvable” letter cited agency concerns that the Augment clinical trial population was “predominantly low-risk and therefore may not have warranted the use of either autograft or Augment Bone Graft,” Wright said.

Read Full Article


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button